XML 111 R41.htm IDEA: XBRL DOCUMENT v3.25.3
Company Overview and Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 73 Months Ended
Aug. 14, 2025
USD ($)
$ / shares
shares
Apr. 23, 2024
USD ($)
Apr. 22, 2024
USD ($)
shares
Apr. 03, 2024
USD ($)
Mar. 22, 2024
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
shares
Sep. 30, 2025
USD ($)
product
shares
Sep. 30, 2024
USD ($)
shares
Sep. 30, 2025
USD ($)
Subsidiary, Sale of Stock [Line Items]                      
Number of commercialized products | product                 4    
Equity distribution agreement                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued in transaction (in shares) | shares           27,315,145          
Consideration received on sale of stock                     $ 81,785
Payments for stock issuance costs                     3,858
Equity distribution agreement | Maximum                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, aggregate offering price   $ 100,000                  
Amended Equity Distribution Agreement                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued in transaction (in shares) | shares             0 0 7,457,627 4,557,220  
Consideration received on sale of stock                 $ 21,261 $ 11,855  
Payments for stock issuance costs                 739 $ 530  
Sale of stock, maximum transaction amount       $ 250              
Remaining authorized amount           $ 78,000 $ 78,000   $ 78,000   $ 78,000
Underwritten Public Offering                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued in transaction (in shares) | shares 21,250,000       16,666,667            
Consideration received on sale of stock $ 79,900                    
Payments for stock issuance costs $ 437   $ 894                
Price per share (in dollars per share) | $ / shares $ 4.00       $ 4.50            
Underwriting discounts $ 5,100   $ 4,651                
Over-Allotment Option                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued in transaction (in shares) | shares     559,801                
Consideration received on sale of stock     $ 72,868